Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sympathetic Nervous System | 19 | 2020 | 74 | 5.880 |
Why?
|
| Medulla Oblongata | 4 | 2018 | 33 | 2.230 |
Why?
|
| Spleen | 10 | 2016 | 192 | 2.090 |
Why?
|
| Aging | 7 | 2017 | 639 | 1.830 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2018 | 21 | 1.280 |
Why?
|
| Rats | 19 | 2020 | 3261 | 0.980 |
Why?
|
| Renal Circulation | 3 | 2020 | 18 | 0.880 |
Why?
|
| Brain Stem | 3 | 2018 | 46 | 0.860 |
Why?
|
| Heart Rate | 11 | 2017 | 248 | 0.860 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2017 | 1534 | 0.810 |
Why?
|
| Fever | 2 | 2013 | 57 | 0.810 |
Why?
|
| Blood Pressure | 12 | 2018 | 613 | 0.780 |
Why?
|
| Rats, Inbred F344 | 8 | 2018 | 228 | 0.760 |
Why?
|
| KATP Channels | 1 | 2020 | 11 | 0.760 |
Why?
|
| Glyburide | 1 | 2020 | 8 | 0.760 |
Why?
|
| Muscle, Skeletal | 2 | 2020 | 257 | 0.690 |
Why?
|
| Animals | 24 | 2020 | 14307 | 0.690 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 19 | 0.670 |
Why?
|
| Neurotransmitter Agents | 1 | 2018 | 57 | 0.660 |
Why?
|
| Cytokines | 3 | 2006 | 569 | 0.620 |
Why?
|
| Sympathomimetics | 1 | 2016 | 8 | 0.590 |
Why?
|
| Ghrelin | 1 | 2016 | 12 | 0.590 |
Why?
|
| Hypothermia | 2 | 2006 | 14 | 0.580 |
Why?
|
| Body Temperature Regulation | 2 | 2006 | 8 | 0.530 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2006 | 25 | 0.520 |
Why?
|
| Hyperthermia, Induced | 3 | 2020 | 17 | 0.520 |
Why?
|
| Vasoconstrictor Agents | 2 | 2005 | 38 | 0.520 |
Why?
|
| Angiotensin II | 2 | 2005 | 92 | 0.490 |
Why?
|
| Kidney | 6 | 2013 | 322 | 0.490 |
Why?
|
| Action Potentials | 2 | 2013 | 219 | 0.480 |
Why?
|
| Heat Stress Disorders | 2 | 2003 | 5 | 0.480 |
Why?
|
| Prosencephalon | 2 | 2003 | 25 | 0.460 |
Why?
|
| Interleukin-1 | 2 | 2003 | 33 | 0.450 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 51 | 0.450 |
Why?
|
| Regional Blood Flow | 5 | 2020 | 47 | 0.440 |
Why?
|
| Gene Expression Regulation | 3 | 2006 | 968 | 0.420 |
Why?
|
| Injections, Intraventricular | 5 | 2016 | 60 | 0.420 |
Why?
|
| Central Nervous System | 2 | 2010 | 130 | 0.390 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2008 | 4 | 0.380 |
Why?
|
| Interleukin-6 | 2 | 2008 | 140 | 0.380 |
Why?
|
| Pressoreceptors | 3 | 2020 | 6 | 0.360 |
Why?
|
| Homeostasis | 2 | 2010 | 172 | 0.360 |
Why?
|
| Male | 13 | 2018 | 18870 | 0.330 |
Why?
|
| Periodicity | 1 | 2007 | 33 | 0.300 |
Why?
|
| Neurons | 2 | 2017 | 1130 | 0.300 |
Why?
|
| Adrenergic Fibers | 1 | 2006 | 3 | 0.300 |
Why?
|
| Microinjections | 3 | 2013 | 55 | 0.260 |
Why?
|
| Research Design | 1 | 2007 | 292 | 0.260 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 17 | 0.250 |
Why?
|
| Hemodynamics | 1 | 2003 | 86 | 0.240 |
Why?
|
| Heart Failure | 1 | 2006 | 230 | 0.240 |
Why?
|
| Brain | 2 | 2008 | 1268 | 0.230 |
Why?
|
| Hot Temperature | 2 | 2018 | 120 | 0.220 |
Why?
|
| Antibodies | 1 | 2003 | 135 | 0.220 |
Why?
|
| Medically Underserved Area | 1 | 2023 | 98 | 0.220 |
Why?
|
| Trust | 1 | 2023 | 119 | 0.210 |
Why?
|
| Body Temperature | 2 | 2013 | 39 | 0.210 |
Why?
|
| Antioxidants | 1 | 2004 | 386 | 0.200 |
Why?
|
| Renal Artery | 1 | 2020 | 7 | 0.190 |
Why?
|
| Sympathectomy | 3 | 2005 | 7 | 0.190 |
Why?
|
| Vasoconstriction | 1 | 2020 | 40 | 0.190 |
Why?
|
| Ferric Compounds | 1 | 2020 | 49 | 0.180 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 53 | 0.180 |
Why?
|
| Bicuculline | 2 | 2013 | 14 | 0.180 |
Why?
|
| Contrast Media | 1 | 2020 | 95 | 0.180 |
Why?
|
| Gene Expression | 2 | 2017 | 639 | 0.170 |
Why?
|
| Carbon | 1 | 2020 | 95 | 0.170 |
Why?
|
| Microarray Analysis | 1 | 2017 | 61 | 0.150 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 54 | 0.150 |
Why?
|
| Electrophysiology | 2 | 2010 | 130 | 0.150 |
Why?
|
| Anesthesia | 1 | 2016 | 14 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 396 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 468 | 0.150 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 29 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2016 | 44 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 131 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2020 | 294 | 0.140 |
Why?
|
| Semiconductors | 1 | 2014 | 10 | 0.130 |
Why?
|
| Porphyrins | 1 | 2014 | 53 | 0.120 |
Why?
|
| Polymers | 1 | 2014 | 117 | 0.120 |
Why?
|
| Spinal Nerves | 1 | 2013 | 4 | 0.120 |
Why?
|
| Thiourea | 1 | 2013 | 4 | 0.120 |
Why?
|
| Citrulline | 1 | 2013 | 7 | 0.120 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 14 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 605 | 0.110 |
Why?
|
| Mesencephalon | 2 | 2003 | 41 | 0.110 |
Why?
|
| Denervation | 2 | 2002 | 26 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1152 | 0.110 |
Why?
|
| Neural Pathways | 2 | 2003 | 120 | 0.110 |
Why?
|
| Autonomic Denervation | 1 | 2009 | 1 | 0.090 |
Why?
|
| Kinetics | 1 | 2010 | 650 | 0.080 |
Why?
|
| Third Ventricle | 1 | 2008 | 2 | 0.080 |
Why?
|
| Electrodes | 1 | 2008 | 43 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2009 | 115 | 0.080 |
Why?
|
| Humans | 3 | 2023 | 34853 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2007 | 40 | 0.080 |
Why?
|
| Age Factors | 1 | 2010 | 1007 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 51 | 0.080 |
Why?
|
| Adrenal Glands | 1 | 2006 | 17 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 859 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 18 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 984 | 0.070 |
Why?
|
| Spin Labels | 1 | 2004 | 8 | 0.060 |
Why?
|
| Computer Systems | 1 | 2004 | 18 | 0.060 |
Why?
|
| Losartan | 1 | 2004 | 31 | 0.060 |
Why?
|
| Superoxides | 1 | 2004 | 51 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 608 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 37 | 0.060 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 4 | 0.060 |
Why?
|
| Tail | 1 | 2003 | 5 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 298 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 27 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 137 | 0.060 |
Why?
|
| Hindlimb | 1 | 2003 | 26 | 0.060 |
Why?
|
| Microspheres | 1 | 2003 | 45 | 0.060 |
Why?
|
| Splanchnic Nerves | 1 | 2003 | 2 | 0.060 |
Why?
|
| Stomach | 1 | 2003 | 43 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 141 | 0.060 |
Why?
|
| Chloralose | 1 | 2003 | 1 | 0.060 |
Why?
|
| omega-N-Methylarginine | 1 | 2003 | 4 | 0.060 |
Why?
|
| Kynurenic Acid | 1 | 2003 | 9 | 0.060 |
Why?
|
| Anesthetics, Intravenous | 1 | 2003 | 4 | 0.060 |
Why?
|
| Rest | 1 | 2003 | 25 | 0.060 |
Why?
|
| GABA Antagonists | 1 | 2003 | 25 | 0.060 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2003 | 47 | 0.060 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 55 | 0.060 |
Why?
|
| Sinus of Valsalva | 1 | 2002 | 2 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 92 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2002 | 14 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 58 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2002 | 59 | 0.050 |
Why?
|
| Heart | 1 | 2003 | 178 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2002 | 60 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2003 | 137 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 600 | 0.050 |
Why?
|
| Magnetics | 1 | 2020 | 36 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 80 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 200 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 323 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 649 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1300 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2014 | 47 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 71 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 1033 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 5668 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1426 | 0.020 |
Why?
|
| Female | 1 | 2020 | 19873 | 0.010 |
Why?
|